NextCare

About:

NextCare offers urgent care and occupational medical services for various illnesses such as cough, diaper rashes, earaches and more.

Website: http://nextcare.com

Twitter/X: nextcare

Top Investors: NXT Capital, Enhanced Equity Fund

Description:

NextCare, Inc., doing business as Nextcare Urgent Care, operates urgent care facilities and on-site employer clinics in Arizona, Colorado, North Carolina, Ohio, Texas, and Virginia. The company offers urgent care and occupational medical services. Its occupational medical services include workers’ compensation injury and illness management, drug screens, physical exams, laboratory and screening tests, digital X-ray, vision screening, and immunization. The company also treats various general illnesses, including abscess incision and drainage, allergic reactions, asthma, athlete’s foot/fungus infections, congestion, cough, diaper rashes, earaches, fevers, flu symptoms, gastrointestinal disorders, insect bites, itchy skin, migraine, nausea, runny nose, sinus infections, skin allergies, sore throat, stomachaches and stomach pains, urinary tract infections, and wound infections; and emergency conditions, such as life-threatening, heart attack or stroke, open fractures, severe bleeding, chest pain, head injury or other major trauma, one-sided weakness or numbness, loss of consciousness, and severe abdominal pain. In addition, it conducts pre-employment, camp, school, sports, and DOT/DMV physical exams; and provides injury treatment, pediatric care, back pain treatment, and immunization services, as well as offers medical discount programs. Further, the company offers lab services in the areas of general medical and injury care, occupational medicine, on-site diagnostic testing, select vaccines, and on-site prescriptions dispensing. NextCare, Inc. was founded in 1993 and is based in Mesa, Arizona.

Total Funding Amount:

$165M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Mesa, Arizona, United States

Founded Date:

1993-01-01

Founders:

Andrew Ray, John Shufeldt

Number of Employees:

1001-5000

Last Funding Date:

2018-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai